Impact of secondary-type mutations in NPM1 mutated AML

Eur J Haematol. 2023 Jul;111(1):165-168. doi: 10.1111/ejh.13979. Epub 2023 May 10.

Authors

Qianghua Zhou^{1

2}, Davidson Zhao¹, Mojgan Zarif^{1

3}, Yu Wing Tony Yeung^{1

2}, Guillaume Richard-Carpentier^{4

5}, Hong Chang^{1

2}

Affiliations

¹ Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
² Department of Laboratory Hematology, Toronto General Hospital, University Health Network, Toronto, Canada.
³ UHN Research Institute, University Health Network, Toronto, Canada.
⁴ Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
⁵ Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.

PMID: 37165755
DOI: 10.1111/ejh.13979

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Leukemia, Myeloid, Acute* / diagnosis
Leukemia, Myeloid, Acute* / genetics
Mutation
Nuclear Proteins* / genetics
Prognosis

Substances

Nuclear Proteins